- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06149273
Treatment of Insomnia in Primary Care Study (TIP)
The goal of this clinical trial is to learn about insomnia treatment among primary care patients with chronic insomnia.
The main question it aims to answer is:
• Does Sleep School (a therapy for insomnia) work well to decrease harm of insomnia? Participants will attend a group therapy intervention once a week for six weeks.
Researchers will compare Sleep School to treatment as usual (short counselling by an educated nurse) to see if the Sleep School works better than treatment as usual in decreasing the harm of insomnia.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elina Bergman, PhD
- Email: elkaro@utu.fi
Study Contact Backup
- Name: Ansa Rantanen, PhD
- Email: atsipp@utu.fi
Study Locations
-
-
-
Turku, Finland, 20014
- University of Turku
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Insomnia severity index (ISI) score at least 8
- insomnia symptoms present at least for 3 months
Exclusion Criteria:
- diagnosed dementia based on medical records
- acute suicidality
- acute psychotic symptoms
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sleep School
Participants attend the Sleep School once a week for six weeks.
|
Sleep school is a structured method for the treatment of insomnia, which is based on cognitive behavioral therapy for insomnia (CBT-I).
The central element of the method is a workbook for the patients.
The essential parts of the method are strengthening the patient's self-efficacy, introducing the therapeutic exercises, and supporting the continued use of the exercises.
The main themes of the Sleep school are information about sleep and the factors affecting it, behavioural components of CBT-I, like restricting the time spent in bed, cognitive components of CBT-I, like constructive worrying -exercise, and the exercises that aim to calm down mind and the autonomic nervous system.
The Sleep School is held by an educated nurse.
|
Active Comparator: Treatment as usual
Participants receive short counselling about insomnia at the enrollment visit.
|
Oral and written information about improving sleep habits given by an educated nurse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change from Baseline in Insomnia Severity Index (ISI) score at 8 weeks
Time Frame: Baseline and Week 8
|
The ISI is a validated self-report tool for assessing the severity, and impact of current insomnia symptoms.
It consists of 7 Likert-scale questions with a total score ranging from 0 to 28 (with higher scores indicating more severe insomnia).
Change = Week 8 score - Baseline score.
|
Baseline and Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change from Baseline in Patient Health Questionnaire 9 (PHQ-9) at 8 weeks
Time Frame: Baseline and Week 8
|
PHQ-9 is a validated self-administered instrument assessing each of the 9 Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria for depression as 0 (not at all) to 3 (nearly every day), and the severity of depression.
Possible scores range from 0 to 27.
Change = Week 8 score - Baseline score.
|
Baseline and Week 8
|
Mean change from Baseline in EUROHIS Quality of Life 8-item Index at 8 weeks
Time Frame: Baseline and Week 8
|
EUROHIS Quality of Life 8-item Index is a validated instrument for the assessment of general quality of life.
There are altogether eight questions about the general, physical, psychological, social, and environmental aspects of quality of life.
Every question is scored from 1 (very poor) to 5 (very good).
All scores can be added together and divided by 8 (the sum of the questions) to obtain the EUROHIS-QOL mean score.
Change = Week 8 score - Baseline score.
|
Baseline and Week 8
|
Mean change from Baseline in Work Ability Score (WAS) at 8 weeks
Time Frame: Baseline and Week 8
|
The WAS is the first item of the Work Ability Index (WAI), a validated instrument for the assessment of work ability.
WAS is a single question "What is your current work ability compared to your lifetime best?"
It has a 0-10 response scale, where 0 stands for "completely unable to work" and 10 stands for "work ability at its best."
The WAS has been shown to have a strong association with the WAI and is reliable in evaluating work ability.
Change = Week 8 score - Baseline score.
|
Baseline and Week 8
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep Duration at Baseline
Time Frame: Baseline
|
Information about sleep duration is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep duration.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep duration.
|
Baseline
|
Sleep Stages at Baseline
Time Frame: Baseline
|
Information about sleep stages is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep stages.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep stages.
|
Baseline
|
Sleep Quality at Baseline
Time Frame: Baseline
|
Information about objective sleep quality is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep quality.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep quality.
|
Baseline
|
Sleep Duration at 8 weeks
Time Frame: Week 8
|
Information about sleep duration is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep duration.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep duration.
|
Week 8
|
Sleep Stages at 8 weeks
Time Frame: Week 8
|
Information about sleep stages is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep stages.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep stages.
|
Week 8
|
Sleep Quality at 8 weeks
Time Frame: Week 8
|
Information about objective sleep quality is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep quality.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep quality.
|
Week 8
|
Mean Change from 8 weeks in Insomnia Severity Index (ISI) score at 16 weeks
Time Frame: Week 8 and Week 16
|
The ISI is a validated self-report tool for assessing the severity, and impact of current insomnia symptoms.
It consists of 7 Likert-scale questions with a total score ranging from 0 to 28 (with higher scores indicating more severe insomnia).
Change = Week 16 score - Week 8 score.
|
Week 8 and Week 16
|
Mean change from Baseline in Patient Health Questionnaire 9 (PHQ-9) at 16 weeks
Time Frame: Baseline and Week 16
|
PHQ-9 is a validated self-administered instrument assessing each of the 9 DSM-IV criteria for depression as 0 (not at all) to 3 (nearly every day), and the severity of depression.
Possible scores range from 0 to 27.
Change = Week 16 score - Baseline score.
|
Baseline and Week 16
|
Mean change from Baseline in EUROHIS Quality of Life 8-item Index at 16 weeks
Time Frame: Baseline and Week 16
|
EUROHIS Quality of Life 8-item Index is a validated instrument for the assessment of general quality of life.
There are altogether eight questions about the general, physical, psychological, social, and environmental aspects of quality of life.
Every question is scored from 1 (very poor) to 5 (very good).
All scores can be added together and divided by 8 (the sum of the questions) to obtain the EUROHIS-QOL mean score.
Change = Week 16 score - Baseline score.
|
Baseline and Week 16
|
Mean change from Baseline in Work Ability Score (WAS) at 16 weeks
Time Frame: Baseline and Week 16
|
The WAS is the first item of the Work Ability Index (WAI), a validated instrument for the assessment of work ability.
WAS is a single question "What is your current work ability compared to your lifetime best?"
It has a 0-10 response scale, where 0 stands for "completely unable to work" and 10 stands for "work ability at its best."
The WAS has been shown to have a strong association with the WAI and is reliable in evaluating work ability.
Change = Week 16 score - Baseline score.
|
Baseline and Week 16
|
Sleep Duration at 16 weeks
Time Frame: Week 16
|
Information about sleep duration is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep duration.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep duration.
|
Week 16
|
Sleep Stages at 16 weeks
Time Frame: Week 16
|
Information about sleep stages is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep stages.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep stages.
|
Week 16
|
Sleep Quality at 16 weeks
Time Frame: Week 16
|
Information about objective sleep quality is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep quality.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep quality.
|
Week 16
|
Mean Change from 8 weeks in Insomnia Severity Index (ISI) score at 26 weeks
Time Frame: Week 8 and Week 26
|
The ISI is a validated self-report tool for assessing the severity, and impact of current insomnia symptoms.
It consists of 7 Likert-scale questions with a total score ranging from 0 to 28 (with higher scores indicating more severe insomnia).
Change = Week 26 score - Week 8 score.
|
Week 8 and Week 26
|
Mean change from Baseline in Patient Health Questionnaire 9 (PHQ-9) at 26 weeks
Time Frame: Baseline and Week 26
|
PHQ-9 is a validated self-administered instrument assessing each of the 9 DSM-IV criteria for depression as 0 (not at all) to 3 (nearly every day), and the severity of depression.
Possible scores range from 0 to 27.
Change = Week 26 score - Baseline.
|
Baseline and Week 26
|
Mean change from Baseline in EUROHIS Quality of Life 8-item Index at 26 weeks
Time Frame: Baseline and Week 26
|
EUROHIS Quality of Life 8-item Index is a validated instrument for the assessment of general quality of life.
There are altogether eight questions about the general, physical, psychological, social, and environmental aspects of quality of life.
Every question is scored from 1 (very poor) to 5 (very good).
All scores can be added together and divided by 8 (the sum of the questions) to obtain the EUROHIS-QOL mean score.
Change = Week 26 score - Baseline score.
|
Baseline and Week 26
|
Mean change from Baseline in Work Ability Score (WAS) at 26 weeks
Time Frame: Baseline and Week 26
|
The WAS is the first item of the Work Ability Index (WAI), a validated instrument for the assessment of work ability.
WAS is a single question "What is your current work ability compared to your lifetime best?"
It has a 0-10 response scale, where 0 stands for "completely unable to work" and 10 stands for "work ability at its best."
The WAS has been shown to have a strong association with the WAI and is reliable in evaluating work ability.
Change = Week 26 score - Baseline score.
|
Baseline and Week 26
|
Sleep Duration at 26 weeks
Time Frame: Week 26
|
Information about sleep duration is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep duration.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep duration.
|
Week 26
|
Sleep Stages at 26 weeks
Time Frame: Week 26
|
Information about sleep stages is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep stages.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep stages.
|
Week 26
|
Sleep Quality at 26 weeks
Time Frame: Week 26
|
Information about objective sleep quality is collected with smart watches using a validated method.
The method is based on assessment of biological signals with artificial intelligence algorithms.
With a smart watch, the participant's heart rate, movements, oxygen saturation, and photoplethysmography signal is measured from the wrist.
The photoplethysmography signal measures optically the changes in blood volume, which enables the assessment of the function of the sympathetic and parasympathetic nervous system.
Albeit having different units, our previously developed deep learning applications utilize information from heart rate, movements, oxygen saturation, and photoplethysmography signals to assess sleep quality.
Thus, regardless of the units of measured signals, information from all of these signals are combined by automatic algorithms to report one single value: sleep quality.
|
Week 26
|
Mean Change from 8 weeks in Insomnia Severity Index (ISI) score at 12 months
Time Frame: Week 8 and 12 Months
|
The ISI is a validated self-report tool for assessing the severity, and impact of current insomnia symptoms.
It consists of 7 Likert-scale questions with a total score ranging from 0 to 28 (with higher scores indicating more severe insomnia).
Change = 12 Month score - Week 8 score.
|
Week 8 and 12 Months
|
Mean change from Baseline in Patient Health Questionnaire 9 (PHQ-9) at 12 months
Time Frame: Baseline and 12 Months
|
PHQ-9 is a validated self-administered instrument assessing each of the 9 DSM-IV criteria for depression as 0 (not at all) to 3 (nearly every day), and the severity of depression.
Possible scores range from 0 to 27.
Change = 12 Month score - Baseline score.
|
Baseline and 12 Months
|
Mean change from Baseline in EUROHIS Quality of Life 8-item Index at 12 months
Time Frame: Baseline and 12 Months
|
EUROHIS Quality of Life 8-item Index is a validated instrument for the assessment of general quality of life.
There are altogether eight questions about the general, physical, psychological, social, and environmental aspects of quality of life.
Every question is scored from 1 (very poor) to 5 (very good).
All scores can be added together and divided by 8 (the sum of the questions) to obtain the EUROHIS-QOL mean score.
Change = 12 Month score - Baseline score.
|
Baseline and 12 Months
|
Mean change from Baseline in Work Ability Score (WAS) at 12 months
Time Frame: Baseline and 12 Months
|
The WAS is the first item of the Work Ability Index (WAI), a validated instrument for the assessment of work ability.
WAS is a single question "What is your current work ability compared to your lifetime best?"
It has a 0-10 response scale, where 0 stands for "completely unable to work" and 10 stands for "work ability at its best."
The WAS has been shown to have a strong association with the WAI and is reliable in evaluating work ability.
Change = 12 Month score - Baseline score.
|
Baseline and 12 Months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Päivi Korhonen, PhD, University of Turku
Publications and helpful links
General Publications
- van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018 Apr;38:3-16. doi: 10.1016/j.smrv.2017.02.001. Epub 2017 Feb 9.
- Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Goncalves M, Hertenstein E, Jansson-Frojmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Weess HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017 Dec;26(6):675-700. doi: 10.1111/jsr.12594. Epub 2017 Sep 5.
- Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med. 2009 Apr;10(4):427-38. doi: 10.1016/j.sleep.2008.04.005. Epub 2008 Aug 26.
- Lallukka T, Kaikkonen R, Harkanen T, Kronholm E, Partonen T, Rahkonen O, Koskinen S. Sleep and sickness absence: a nationally representative register-based follow-up study. Sleep. 2014 Sep 1;37(9):1413-25. doi: 10.5665/sleep.3986.
- Javaheri S, Redline S. Insomnia and Risk of Cardiovascular Disease. Chest. 2017 Aug;152(2):435-444. doi: 10.1016/j.chest.2017.01.026. Epub 2017 Jan 30.
- Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010 Feb;14(1):69-82. doi: 10.1016/j.smrv.2009.07.004. Epub 2009 Dec 4.
- Overland S, Glozier N, Sivertsen B, Stewart R, Neckelmann D, Krokstad S, Mykletun A. A comparison of insomnia and depression as predictors of disability pension: the HUNT Study. Sleep. 2008 Jun;31(6):875-80. doi: 10.1093/sleep/31.6.875.
- Johnson KA, Gordon CJ, Chapman JL, Hoyos CM, Marshall NS, Miller CB, Grunstein RR. The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis. Sleep Med Rev. 2021 Oct;59:101456. doi: 10.1016/j.smrv.2021.101456. Epub 2021 Jan 23.
- Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011 Dec;135(1-3):10-9. doi: 10.1016/j.jad.2011.01.011. Epub 2011 Feb 5.
- Ragnoli B, Pochetti P, Raie A, Malerba M. Comorbid Insomnia and Obstructive Sleep Apnea (COMISA): Current Concepts of Patient Management. Int J Environ Res Public Health. 2021 Sep 1;18(17):9248. doi: 10.3390/ijerph18179248.
- Ballesio A, Aquino MRJV, Feige B, Johann AF, Kyle SD, Spiegelhalder K, Lombardo C, Rucker G, Riemann D, Baglioni C. The effectiveness of behavioural and cognitive behavioural therapies for insomnia on depressive and fatigue symptoms: A systematic review and network meta-analysis. Sleep Med Rev. 2018 Feb;37:114-129. doi: 10.1016/j.smrv.2017.01.006. Epub 2017 Feb 7.
- Alimoradi Z, Jafari E, Brostrom A, Ohayon MM, Lin CY, Griffiths MD, Blom K, Jernelov S, Kaldo V, Pakpour AH. Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis. Sleep Med Rev. 2022 Aug;64:101646. doi: 10.1016/j.smrv.2022.101646. Epub 2022 May 10.
- van der Zweerde T, Bisdounis L, Kyle SD, Lancee J, van Straten A. Cognitive behavioral therapy for insomnia: A meta-analysis of long-term effects in controlled studies. Sleep Med Rev. 2019 Dec;48:101208. doi: 10.1016/j.smrv.2019.08.002. Epub 2019 Aug 12.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VARHA/480/13.02.02/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia Chronic
-
University of AarhusTrygFonden, Denmark; Enversion A/SActive, not recruiting
-
Posit Science CorporationCompletedInsomnia ChronicUnited States
-
Jun SongUnknown
-
University of ManitobaCompleted
-
University of Missouri-ColumbiaUniversity of FloridaCompleted
-
University of AarhusTrygFonden, Denmark; Enversion A/SCompleted
-
University of TromsoUniversity Hospital of North Norway; Diakonhjemmet HospitalNot yet recruitingPain, Chronic | Insomnia Chronic | Insomnia Due to Medical ConditionNorway
-
University of Missouri-ColumbiaCompletedPain, Chronic | Insomnia ChronicUnited States
-
Diakonhjemmet HospitalActive, not recruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Chronic Disease | Sleep Disturbance | Insomnia Chronic | Insomnia Due to Medical Condition | Insomnia, PsychophysiologicalNorway
Clinical Trials on Sleep School
-
Universidad de GranadaUnknown
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH) and other collaboratorsCompleted
-
Universitair Ziekenhuis BrusselVrije Universiteit BrusselCompletedLumbar RadiculopathyBelgium
-
International Food Policy Research InstituteFHI 360; Addis Continental Institute of Public HealthCompletedDietary DiversityUnited States
-
Seattle Children's HospitalCompletedObesity | Physical Activity | Injury Prevention | Pedestrian SafetyUnited States
-
The University of Texas Health Science Center,...National Institute of Dental and Craniofacial Research (NIDCR)RecruitingCaries,DentalUnited States
-
St. Jude Children's Research HospitalNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingSickle Cell DiseaseUnited States
-
Stanford UniversityCenters for Disease Control and Prevention; Association of American Medical...Completed
-
Samara State Medical UniversityActive, not recruitingSchool Readiness | School AdaptationRussian Federation
-
University of ZurichLund University; Kantonsspital Aarau; Maastricht University; Kantonsspital OltenCompleted